News
Sanofi invests $40m in UK gene therapy company Gyroscope Therapeutics
London, UK-based gene therapy company Gyroscope Therapeutics has announced investment from Sanofi totalling up to $60m, with $40m to be invested initially.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
London, UK-based gene therapy company Gyroscope Therapeutics has announced investment from Sanofi totalling up to $60m, with $40m to be invested initially.